Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTN - Palatin Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (9)	1/12/2001 2:13:17 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 142

Early competition for one of ptn's interesting (almost said sexiest) preclinical candidates: 1: J Med Chem 2000 Dec 28;43(26):4927-9 Related Articles, Books Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase. Ohmoto K, Yamamoto T, Horiuchi T, Imanishi H, Odagaki Y, Kawabata K, Sekioka T, Hirota Y, Matsuoka S, Nakai H, Toda M, Cheronis JC, Spruce LW, Gyorkos A, Wieczorek M Gonex, Inc., Colorado State University, ARBL, Ft. Collins, Colorado 80523-1683, USA. [Medline record in process] PMID: 11150162, UI: 20584344 Any significance to ptn not archiving its HQ presentation? Save a few bucks, too close to secondary, needed editing? --Wilder (mind if I be a cabbose for a little while?)